Genetics

Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria 
Condition: Phenylketonuria
Intervention: Drug: rAvPAL-PEG
Principal Investigator: Barbara K. Burton, M.D.
Phone: 773-880-4462
IRB Number: 2008-13453 (ClinicalTrials.gov identifier: NCT00634660)
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study 
Principal Investigator: Joel Charrow, MD
Contact: Shanna Randolph, APN
Phone: 773-880-4462
Email: srandolph@childrensmemorial.org  
ClinicalTrials.gov identifier: NCT00446862
International Collaborative Gaucher Group (ICGG) Gaucher Registry 
Principal Investigator: Joel Charrow, MD
Phone: 773-880-4462
Email: jcharrow@northwestern.edu  
ClinicalTrials.gov Identifier: NCT00358943
Pompe Disease Registry 
Principal Investigator: Joel Charrow, MD
Phone: 773-880-4462
Email: jcharrow@northwestern.edu  
ClinicalTrials.gov Identifier: NCT00231400
Fabry Disease Registry 
Principal Investigator: Joel Charrow, MD
Phone: 773-880-4462
Email: jcharrow@northwestern.edu
ClinicalTrials.gov identifier: NCT00196742

 

Back to the top of the page